FIELD: medicine, oncology, urology. SUBSTANCE: invention relates to method for treatment of prostate tumors. For this purpose cetrorelix is administrated in the dose 0.5 mg/day as monotherapy or in combination with inhibitors of α-reductase or agents blocking adrenergic receptors. Method provides reduction of prostate volume and eliminates by-side effects of castration level of testosterone. EFFECT: enhanced effectiveness of treatment. 4 cl, 4 dwg, 2 ex
Authors
Dates
2003-11-10—Published
1997-09-01—Filed